(CELH) Celsius Holdings - Ratings and Ratios
Functional Energy Drinks, Hydration Powders, Ready-To-Drink
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 70.5% |
| Value at Risk 5%th | 95.9% |
| Relative Tail Risk | -17.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.33 |
| Alpha | 65.84 |
| CAGR/Max DD | 0.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.475 |
| Beta | 0.859 |
| Beta Downside | 0.757 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.86% |
| Mean DD | 36.63% |
| Median DD | 36.05% |
Description: CELH Celsius Holdings January 02, 2026
Celsius Holdings, Inc. (NASDAQ: CELH) manufactures and markets a portfolio of functional energy beverages-including CELSIUS Originals, Vibe, Essentials, On-the-Go Powder, and Hydration powders-across carbonated, non-carbonated, and ready-to-drink formats. The brand is sold through a broad channel mix: direct-to-store delivery, independent distributors, supermarkets, convenience and drug stores, specialty nutrition retailers, gyms, food-service operators, mass merchants, and e-commerce platforms.
In FY 2023 the company reported revenue of roughly $2.5 billion, a year-over-year increase of about 30%, driven by double-digit volume growth in both the U.S. and international markets. Gross margin expanded to 57% as the product mix shifted toward higher-margin powder and zero-sugar formats, while the broader non-alcoholic beverage sector benefits from sustained consumer demand for low-calorie, performance-oriented drinks and from a macro-trend toward healthier lifestyle choices.
For a deeper quantitative breakdown, the ValueRay platform provides a granular view of CELH’s financial metrics, peer benchmarks, and scenario analyses that can help sharpen your investment thesis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (64.4m TTM) > 0 and > 6% of Revenue (6% = 127.6m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -0.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 42.93% (prev 78.35%; Δ -35.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 554.6m > Net Income 64.4m (YES >=105%, WARN >=100%) |
| Net Debt (55.5m) to EBITDA (129.6m) ratio: 0.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (237.2m) change vs 12m ago 1.49% (target <= -2.0% for YES) |
| Gross Margin 51.38% (prev 49.59%; Δ 1.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 61.00% (prev 80.43%; Δ -19.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.94 (EBITDA TTM 129.6m / Interest Expense TTM 36.3m) >= 6 (WARN >= 3) |
Altman Z'' 1.52
| (A) 0.17 = (Total Current Assets 1.94b - Total Current Liabilities 1.03b) / Total Assets 5.27b |
| (B) 0.03 = Retained Earnings (Balance) 165.5m / Total Assets 5.27b |
| (C) 0.03 = EBIT TTM 106.7m / Avg Total Assets 3.49b |
| (D) 0.07 = Book Value of Equity 168.1m / Total Liabilities 2.30b |
| Total Rating: 1.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.93
| 1. Piotroski 4.0pt |
| 2. FCF Yield 3.82% |
| 3. FCF Margin 24.63% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda 0.43 |
| 6. ROIC - WACC (= -2.75)% |
| 7. RoE 3.41% |
| 8. Rev. Trend 89.47% |
| 9. EPS Trend 29.89% |
What is the price of CELH shares?
Over the past week, the price has changed by +10.40%, over one month by +21.10%, over three months by -13.17% and over the past year by +95.69%.
Is CELH a buy, sell or hold?
- Strong Buy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CELH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.1 | 18.9% |
| Analysts Target Price | 63.1 | 18.9% |
| ValueRay Target Price | 64.3 | 21.1% |
CELH Fundamental Data Overview January 12, 2026
P/E Forward = 35.461
P/S = 6.4148
P/B = 11.3347
P/EG = 0.8617
Beta = 0.88
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 13.69b USD (13.64b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
EV/FCF = 26.15x (Enterprise Value 13.69b / FCF TTM 523.6m)
FCF Yield = 3.82% (FCF TTM 523.6m / Enterprise Value 13.69b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 2.60 (Enterprise Value 13.69b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 30.69% (-27.0m / -88.0m)
NOPAT = 74.0m (EBIT 106.7m * (1 - 30.69%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.85% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 5.87% (NOPAT 74.0m / Invested Capital 1.26b)
WACC = 8.63% (E(13.64b)/V(14.50b) * Re(9.08%) + D(861.5m)/V(14.50b) * Rd(2.12%) * (1-Tc(0.31)))
Discount Rate = 9.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 76.51% ; FCFF base≈382.0m ; Y1≈399.2m ; Y5≈461.4m
Fair Price DCF = 27.57 (EV 7.16b - Net Debt 55.5m = Equity 7.11b / Shares 257.8m; r=8.63% [WACC]; 5y FCF grow 4.81% → 2.90% )
EPS Correlation: 29.89 | EPS CAGR: -0.90% | SUE: -3.57 | # QB: 0
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=-0.003 | Revisions Net=+0 | Analysts=11
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=-0.002 | Revisions Net=+2 | Growth EPS=+22.2% | Growth Revenue=+31.6%
Additional Sources for CELH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle